research use only
Cat.No.S6994
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel Potassium Channel GABA Receptor TRP Channel ATPase |
|---|---|
| Other PROTAC Inhibitors | dBET6 dBET1 (+)-JQ1 carboxylic acid ACBI1 ARV-771 A1874 YD54 YDR1 YD23 TL12-186 |
|
In vitro |
DMSO
: 100 mg/mL
(114.93 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 870.07 | Formula | C46H59N7O8S |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2305936-56-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=C(SC=N1)C2=CC=C(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)CCCCCCCCCCNC4=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=CC=C4)C(C)(C)C)C=C2 | ||
| Targets/IC50/Ki |
CRBN
20.4 nM(DC50)
|
|---|---|
| In vitro |
Treatment with TD-165 causes a concentration-dependent decrease in the level of CRBN proteins by Western blot analysis. |
| In vivo |
TD-165 do not affect CRBN levels in the spleen, peripheral blood mononuclear cells (PBMCs), or liver of mice by immunoblotting, which might be attributable to the high plasma protein binding of this compound. |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.